• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • Investors
  • Media
  • Contact Us
  • LinkedIn
  • Twitter
  • Our Company
    • Our Values
    • Our Executive Team
    • Our Board of Directors
    • Open Payments and Transparency
  • Our Product
    • Discovery of Linaclotide
  • Our Pipeline
  • Partnerships
  • Patients
  • Join Us
    • Open Positions
    • Internships, Co-ops and Fellowships
    • Things You Should Know
  • LinkedIn
  • Twitter
  • Our Company
    • Our Values
    • Our Executive Team
    • Our Board of Directors
    • Open Payments and Transparency
  • Our Product
    • Discovery of Linaclotide
  • Our Pipeline
  • Partnerships
  • Patients
  • Investors
    • Events & Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Investor FAQ
    • Press Releases
    • Investor Contacts
  • Join Us
    • Open Positions
    • Internships, Co-ops and Fellowships
    • Things You Should Know
  • Media

Ironwood is a healthcare company dedicated to making a difference for people living with gastrointestinal (GI) diseasesIronwood Pharmaceuticals

Media Releases

July 22, 2021

Ironwood Pharmaceuticals to Host Second Quarter 2021 Investor Update Call

June 16, 2021

Ironwood Pharmaceuticals Announces That The American Journal of Gastroenterology Publishes Full Results from Positive LINZESS® (linaclotide) Phase IIIb Trial in Adults with Irritable Bowel Syndrome with Constipation (IBS-C)

Learn About Our Pipeline

View

Interested in Joining Our Team?

View
    Our Company
    • Our Values
    • Our Executive Team
    • Our Board of Directors
    • Open Payments and Transparency
    Our Product
    • Discovery of Linaclotide
    • Report a possible side effect
    Our Pipeline
    Partnerships
    Patients
    Join Us
    • Open Positions
    • Internships, Co-ops and Fellowships
    • Things You Should Know
    Investors
    • Events & Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Investor FAQ
    • Press Releases
    • Investor Contacts
    Media
    Contact Us
  • Follow Us
  • LinkedIn
  • Twitter
  • Privacy Policy
  • Terms of Use
  • California Privacy Policy
  • Site Map
  • Contact Us

Copyright © 2021, Ironwood Pharmaceuticals, Inc. All Rights Reserved

LINZESS®, CONSTELLA®, IRONWOOD® and their associated logos are trademarks of Ironwood Pharmaceuticals, Inc. Any other trademarks referred to herein are the property of their respective owners. All rights reserved.

You are now leaving www.IronwoodPharma.com.

This link will take you to a website to which our privacy policy does not apply. You are solely responsible for your interactions with that website.

  • Continue
  • Cancel